002932SZSE
🚨 Material Event

Report on the Implementation of Major Asset Purchase

Wuhan Easy Diagnosis Biomedicine Co., Ltd.··15 pages

✨ AI Summary

Wuhan Mingde Biotech Co., Ltd. has completed the acquisition of 100% equity in Wuhan Biker Rescue Supplies Co., Ltd. from Blue Sail Medical Co., Ltd. for a total cash consideration of 190 million RMB. This report confirms the completion of asset transfer, registration, and relevant legal procedures. The transaction aims to integrate the target company's assets into the issuer's operations.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Stock Code: 002932 Stock Abbreviation: *ST Mingde Listing Venue: Shenzhen Stock Exchange

[Image: Company Logo]

Wuhan Mingde Biotech Co., Ltd.

Report on the Implementation of Major Asset Purchase

Independent Financial Advisor

Changjiang Financing Services Co., Ltd.

August 2026

Company Statement

The Company and all directors and senior management guarantee the truthfulness, accuracy, and completeness of the contents of this report, and assume corresponding legal liability for any false records, misleading statements, or major omissions in this report. Other relevant parties to this transaction have promised that the documents and materials provided are true, accurate, and complete, and contain no false records, misleading statements, or major omissions.

Any decisions or opinions made by relevant regulatory authorities regarding this transaction do not represent a substantive judgment or guarantee of the value of the Company's shares or investor returns. Any statement to the contrary is a false and untrue statement.

After the completion of this transaction, the Company is responsible for changes in its operations and earnings; investors shall bear the investment risks arising from this transaction. If investors have any questions regarding this report, they should consult their stock brokers, lawyers, professional accountants, or other professional advisors.

Table of Contents

  1. Company Statement

  2. Table of Contents

  3. Definitions

Section 1 Overview of the Transaction

  1. Specific Plan for the Transaction

  2. Nature of the Transaction

Section 2 Implementation of the Transaction

  1. Decision-making and Approval of the Transaction

  2. Handling of Asset Transfer or Delivery and Related Creditor-Debtor Matters

  3. Differences Between Actual Implementation and Previously Disclosed Information

  4. Changes in Directors, Supervisors, and Senior Management of the Target and Adjustments to Other Relevant Personnel

  5. Whether Funds or Assets of the Listed Company Were Occupied by the Actual Controller or Other Related Parties, or Whether the Listed Company Provided Guarantees for the Actual Controller and Their Related Parties During the Restructuring

  6. Performance of Relevant Agreements and Commitments

  7. Compliance and Risks of Relevant Subsequent Matters

Section 3 Conclusions of Intermediary Agencies on the Implementation of the Transaction

  1. Conclusion of the Independent Financial Advisor on the Implementation of the Transaction

  2. Conclusion of the Legal Advisor on the Implementation of the Transaction

Section 4 Documents Available for Inspection

  1. Documents Available for Inspection

  2. Locations for Inspection

Definitions

In this report, unless the context otherwise requires, the following abbreviations and terms have the following meanings:

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Sign in to read moreSee Pro pricing